Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association

Abstract

Long-chain omega-3 fatty acids could have neuroprotective properties against dementia, which is becoming a major global public health issue. We conducted a systematic review of the literature to establish the association between eating fish (a source of long-chain omega-3 fatty acids) or taking long-chain omega-3 fatty acid supplements and the risk of cognitive decline or Alzheimer disease (AD). We identified eleven observational studies and four clinical trials. All three observational studies that used cognitive decline as an outcome reported significant benefits, whereas only four of eight observational studies that used incidence of AD or dementia as an outcome reported positive findings. None of four small clinical trials provided convincing evidence for the use of this approach in the prevention or treatment of any form of dementia. In summary, the existing data favor a role for long-chain omega-3 fatty acids in slowing cognitive decline in elderly individuals without dementia, but not for the prevention or treatment of dementia (including AD). This apparent dichotomy might reflect differences in study designs with regard to participants, dosages, the ratio of long-chain omega-3 to omega-6 fatty acids, or the choice of outcome measurements. Large clinical trials of extended duration should help to provide definitive answers.

Dietary interventions as a neuroprotective therapy for the delay of the onset of cognitive decline in older adults: Evaluation of the evidence

“…Fotuhi et al 2009 [38] Systematic review III-3 Three cohort studies of 210-3,718 elderly participants of 4-6 years duration reported that omega-3 PUFA was associated with a modest benefit in slowing cognitive decline in elderly individuals without dementia.…”

The relationship of diet and acne

“…84 Other studies have shown that omega 3 fatty acids could have similar effect in AD patients. 85,86 A recent review which referred to the sebaceous gland as the "brain of the skin" has opened the horizons to the newly founded field of dermatoendocrinology. 87 The paper discussed the links between the endocrine system and sebaceous glands.…”

Development and Optimization of Chromatographic Systems for Separation of Fatty Acids by Gas Chromatographic Method

“…[12] α-Linolenic acid is the basic for formation of Docosahexaenoic acid and Eicosapentaenoic acid, which are important for function of immune, cardiovascular and nervous systems. [13] Low Docosahexaenoic acid levels are associated with depression, schizophrenia [14] , memory loss [15,16] , increased risk of development of Alzheimer's disease [17] , low birth weight and hyperactivity in children. Patients suffering from Alzheimer's disease after supplementation with Eicosapentaenoic acid and Docosahexaenoic acid recover cognitive deficits [12] and Docosahexaenoic acid improve memory and reaction time in adults.…”